10 days rolling since the unblinding of the CD-12 trial.
10 days rolling since the unblinding of the CD-12 trial. How much longer will it take? I am dying here. (Not literally). It’s like the old commercial... how many licks does it take to get to the center of the tootsie pop? As impatient as I am. I have never been able to count without the crunch and ending the attempt.
The sooner this all is presented to the shareholders and the rest of the world.... all the better. If it doesn’t happen soon... I might have to do what CDiddy suggested that he might do and stake out the head quarters of Cytodyn. It’s a great idea. Since they are kind of in my backyard so to speak and kinda local to me... same State and all... I would like to see how Cytodyn company employees are coming and going and what kind of signals I can pick up from the body language. Maybe I will see Nader jumping high up and kicking his heels together before he lands on his way in to the office? Or maybe a nice pat on the back from Nader to Mahboob for a job well done! Something of unmistakeable joy shared by our management team that installs the excitement for everyone when I report back to the board. Hopefully something that builds our confidence that the management might be able to share soon with all of us.
I am getting kinda desperate here and just want to see the good times roll. Watch the blossoming of a fledgling drug that helps to save the world. Is that too much to ask?
I love the fact that no matter the variant mutation or even new strain of COVID-19 that we are still in the game as a go to future therapeutic. I remember when Dr BP said that all countries should stock pile Leronlimab for the next future pandemic. Let’s get on it and serve up some kick ass results that amaze us all. So we can provide for this current pandemic and know that the future is bright for Vyrologix. This waiting game is getting very very old.
This is my hope and order of catalysts to come. This week we show great trial results and then uplist and then since the results are so great we get the nod in one day for an EUA. (Beating Remdeathisnear in their two day sped up EUA approval). All this happening before the end of this month. Now that’s kicking some butt. It’s what dreams are made of! It’s what we need to happen to start saving many many lives.
By the way... didn’t even get one number right on my Mega Millions tickets. So I thought I would post my imagination of what if’s... once again.
Damn... that would of been a nice lotto to win. A cool billion.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...
Continue Reading
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...
Continue Reading
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Top 5 Most Recently Viewed Articles
The International Energy Agency (IEA) flagged back in 2024 that the world was stepping into a new chapter in energy markets, with whispers of affordable prices on the horizon. The game-changer? A surge in electricity use was creating global surpluses of oil and gas resources, setting the stage for a whole new dynamic. Global Energy Trends: Demand Shifts or Supply Surges?...
Continue Reading
BayCare Announces Exciting Leadership Change In a significant move towards enhancing its operational effectiveness, BayCare has appointed Kristen A. Vogl, PT, DPT, MBA, as the new vice president of service lines. With over two decades of experience in various healthcare settings, Vogl is set to elevate BayCare's mission of providing excellent care and improving patient...
Continue Reading
Optimistic Outlook for Investor Favorites In a recent update, leading Wall Street analysts have revised their ratings, signaling an optimistic trend for several prominent companies. Analysts have made notable upgrades, reflecting growing confidence in these stocks' future performance. Let's explore five significant upgrades and what they mean for investors. Ecolab Inc...
Continue Reading
Key Earnings Reports Coming Up As we move deeper into earnings season, several significant companies are set to unveil their financial results. Among these, State Street (NYSE: STT), a major player in the financial services industry, stands out this Friday, accompanied by oil giant Schlumberger and the well-known regional bank, Regions Financial (NYSE: RF). These...
Continue Reading
Kenneth Fisher Joins APA Corporation's Board of Directors APA Corporation (NASDAQ: APA) is excited to announce a significant leadership change with the appointment of Kenneth M. Fisher to its board of directors. A Warm Welcome to Ken Fisher Lamar McKay, APA’s non-executive board chair, expressed enthusiasm about Fisher’s addition to the board. He stated, “We are...
Continue Reading